Leadership Update: Geoff Matthews is appointed Chief Scientific Officer

Aculeus is pleased to announce the promotion of Geoff Matthews, previously Head of Immunobiology, to the role of Chief Scientific Officer (CSO). Geoff’s leadership in immunobiology has deeply influenced our approach to drug discovery, and this promotion reflects his continued impact on Aculeus as we move further into clinical development.